Search results for " CD"

showing 10 items of 587 documents

A Cytologic Assay for Diagnosis of Food Hypersensitivity in Patients With Irritable Bowel Syndrome

2010

BACKGROUND & AIMS: A percentage of patients with symptoms of irritable bowel syndrome (IBS) suffer from food hypersensitivity (FH) and improve on a food-elimination diet. No assays have satisfactory levels of sensitivity for identifying patients with FH. We evaluated the efficacy of an in vitro basophil activation assay in the diagnosis of FH in IBS-like patients. METHODS: Blood samples were collected from 120 consecutive patients diagnosed with IBS according to Rome II criteria. We analyzed in vitro activation of basophils by food allergens (based on levels of CD63 expression), as well as total and food-specific immunoglobulin (Ig)E levels in serum. Effects of elimination diets and dou…

AdultMalefood hypersensitivitySettore MED/09 - Medicina InternaAdolescentCytologic assay; food hypersensitivity; irritable bowel diseaseCytological Techniquesirritable bowel diseasePlatelet Membrane GlycoproteinsImmunoglobulin ESensitivity and SpecificityIrritable Bowel SyndromeYoung AdultAntigenAntigens CDElimination dietmedicineAnimalsHumansYoung adultCells CulturedIrritable bowel syndromeCytologic assayHepatologybiologyCD63Tetraspanin 30business.industryGastroenterologyAllergensImmunoglobulin EMiddle Agedmedicine.diseaseBasophilsBasophil activationImmunologybiology.proteinFemaleAntibodybusinessClinical Gastroenterology and Hepatology
researchProduct

Relapse Rate in Survivors of Acute Autoimmune Thrombotic Thrombocytopenic Purpura Treated with or without Rituximab.

2018

Background Autoimmune thrombotic thrombocytopenic purpura (iTTP) is caused by autoantibody-mediated severe a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13 (ADAMTS13) deficiency leading to micro-angiopathic haemolytic anaemia (MAHA) and thrombocytopenia with organ damage. Patients survive with plasma exchange (PEX), fresh frozen plasma replacement and corticosteroid treatment. Anti-CD20 monoclonal antibody rituximab is increasingly used in patients resistant to conventional PEX or relapsing after an acute bout. Objective This retrospective observational study focused on the relapse rate and possible influencing factors including treatment with rituximab first…

AdultMalemedicine.medical_specialtyAdolescentautoantibodiesThrombotic thrombocytopenic purpuraADAMTS13 ProteinRelapse rate030204 cardiovascular system & hematologyGastroenterologyAutoimmune Diseases03 medical and health sciencesYoung Adult0302 clinical medicineSex FactorsRecurrenceInternal medicinehemic and lymphatic diseasesCellular Haemostasis and PlateletsMedicineHumansImmunologic Factorsclinical studiesYoung adultChildADAMS/ADAMTS13Retrospective StudiesPurpura Thrombotic Thrombocytopenicbusiness.industryRetrospective cohort studyHematologythrombotic thrombocytopenic purpura (TTP/HUS)Middle Agedmedicine.diseaseAntigens CD20ADAMTS13PurpuraTreatment Outcome030220 oncology & carcinogenesisRituximabFemaleFresh frozen plasmamedicine.symptombusinessRituximabmedicine.drugFollow-Up StudiesThrombosis and haemostasis
researchProduct

Memory B Cell Subpopulations in the Aged

2006

The literature on immunosenescence has focused mainly on T cell impairment. With the aim of gaining insight into B cell immunosenescence, the authors investigated the serum IgD levels in 24 young and 21 old people and analyzed their relationship with the number of CD19 CD27 memory cells. Serum IgD were quantified by the use of radial immunodiffusion and the lymphocyte population CD19 CD27 was identified by a FACScan flow cytometer. Serum IgD levels were significantly lower (p 0.0001) in old subjects, and the percentage of CD19 CD27 lymphocytes were significantly increased (p 0.01) in old subjects. Finally, a significant negative correlation was found (p 0.01) between serum concentrations of…

AdultMalemedicine.medical_specialtyAgingLymphocyteT cellPopulationAntigens CD19B-Lymphocyte Subsetschemical and pharmacologic phenomenaimmunosenescence memory B cells IgD CD27Immunoglobulin DCD19immune system diseaseshemic and lymphatic diseasesInternal medicinemedicineHumanseducationMemory B cellB cellAgedAged 80 and overSettore MED/04 - Patologia Generaleeducation.field_of_studybiologyhemic and immune systemsImmunosenescenceImmunoglobulin DTumor Necrosis Factor Receptor Superfamily Member 7Endocrinologymedicine.anatomical_structureImmunologybiology.proteinFemaleGeriatrics and GerontologyImmunologic Memory
researchProduct

Filgrastim mobilization and collection of allogeneic blood progenitor cells from adult family donors: first interim report of a prospective German mu…

2002

Recombinant human granulocyte colony-stimulating factor (rhG-CSF) mobilized peripheral blood progenitor cells (PBPCs) from healthy individuals are a rapidly emerging alternative source to bone marrow for allogeneic transplantation. Although widely applied in the meantime, only limited information on feasibility and safety of mobilization and collection of PBPCs is currently available from prospective multicenter studies specifically designed to investigate this donation modality. This ongoing multicenter study on the performance as well as the short- and long-term safety profile of rhG-CSF-induced mobilization and collection of PBPCs was initiated in October 1999. The study is designed to r…

AdultMalemedicine.medical_specialtyAllogeneic transplantationAdolescentFilgrastimAntigens CD34Blood DonorsFilgrastimImmunophenotypingNuclear FamilyInternal medicineGranulocyte Colony-Stimulating FactormedicineClinical endpointHumansLeukapheresisProspective StudiesProspective cohort studyAdverse effectbusiness.industryHematologyGeneral MedicineLeukapheresisMiddle AgedHematopoietic Stem Cell MobilizationLymphocyte SubsetsRecombinant ProteinsGranulocyte colony-stimulating factorSurgeryBlood Cell CountRegimenImmune SystemFemalebusinessmedicine.drugAnnals of hematology
researchProduct

Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobil…

2005

The optimal approach to obtain an adequate graft for transplantation in patients with poor peripheral blood stem cell (PBSC) mobilization remains unclear. We retrospectively assessed the impact of different strategies of second-line stem cell harvest on the transplantation outcome of patients who failed PBSC mobilization in our institution. Such patients were distributed into three groups: those who proceeded to steady-state bone marrow (BM) collection (group A, n = 34); those who underwent second PBSC mobilization (group B, n = 41); those in whom no further harvesting was carried out (group C, n = 30). PBSC harvest yielded significantly more CD34+ cells than BM collection. Autologous trans…

AdultMalemedicine.medical_specialtyAntigens CD34Bone Marrow CellsCell CountTransplantation AutologousInternal medicineGranulocyte Colony-Stimulating FactorMedicineAutologous transplantationHumansLeukapheresisHematopoietic Stem Cell MobilizationAgedBone Marrow TransplantationRetrospective StudiesTransplantationPeripheral Blood Stem Cell TransplantationHematologyBlood Cellsbusiness.industryHematologyLeukapheresisMiddle AgedHematopoietic Stem Cell MobilizationGranulocyte colony-stimulating factorSurgeryTransplantationmedicine.anatomical_structureTreatment OutcomeHematologic NeoplasmsFemaleBone marrowStem cellbusinessBone marrow transplantation
researchProduct

Circulating hematopoietic progenitor cells in runners

2002

Because endurance exercise causes release of mediators and growth factors active on the bone marrow, we asked whether it might affect circulating hematopoietic progenitor cells (HPCs) in amateur runners [ n = 16, age: 41.8 ± 13.5 (SD) yr, training: 93.8 ± 31.8 km/wk] compared with sedentary controls ( n = 9, age: 39.4 ± 10.2 yr). HPCs, plasma cortisol, interleukin (IL)-6, granulocyte colony-stimulating factor (G-CSF), and the growth factor fms-like tyrosine kinase-3 (flt3)-ligand were measured at rest and after a marathon (M; n = 8) or half-marathon (HM; n = 8). Circulating HPC counts (i.e., CD34+cells and their subpopulations) were three- to fourfold higher in runners than in controls at b…

AdultMalemedicine.medical_specialtyMarathonTime FactorsHydrocortisonePhysiologymedicine.medical_treatmentPhysical Therapy Sports Therapy and RehabilitationAntigens CD34Settore MED/10 - Malattie Dell'Apparato RespiratorioSettore BIO/09 - FisiologiaRunningEndocrinologyReference ValuesEndurance trainingPhysiology (medical)Internal medicineGranulocyte Colony-Stimulating FactormedicineHumansOrthopedics and Sports MedicineProgenitor cellCytokineBlood CellsPhysical Education and TrainingHematopoietic cellInterleukin-6business.industryGrowth factorMembrane ProteinsGrowth factorMiddle AgedHematopoietic Stem CellsEndurance trainingBlood Cell CountCytokinemedicine.anatomical_structureEndocrinologyembryonic structuresImmunologyPhysical EnduranceHematopoietic progenitor cellsBone marrowCytokines; Endurance training; Growth factors; Marathon; Physiology; Endocrinology; Orthopedics and Sports Medicine; Physical Therapy Sports Therapy and Rehabilitationbusinesshuman activities
researchProduct

TNF-α, IL-17, and IL-22 production in the rectal mucosa of nonceliac wheat sensitivity patients: role of adaptive immunity.

2020

In recent years, a new gluten- or wheat-related disease has emerged, a condition labeled "nonceliac gluten sensitivity" (NCGS) or "nonceliac wheat sensitivity" (NCWS). NCWS pathogenesis is still uncertain and attributed to very different mechanisms. We aimed to study the different T-lymphocyte subsets in the rectal mucosa of NCWS patients to demonstrate the possible contribution of adaptative immune response. Twelve patients (11 women, 1 man, age range 23-61 yr, median 32 yr) with a definitive diagnosis of NCWS were recruited at random for the present study. They underwent rectal endoscopy with multiple mucosal biopsies at the end of a double-blind placebo-controlled (DBPC) wheat challenge …

AdultMalemedicine.medical_specialtyNecrosisSettore MED/09 - Medicina InternaPhysiologynon-celiac wheat sensitivityBiopsyTNFWheat HypersensitivityAdaptive ImmunityGastroenterologyInterleukin 22PathogenesisYoung AdultImmune systemDouble-Blind MethodAntigens CDPhysiology (medical)Internal medicinemedicineIL-22HumansMucous MembraneHepatologybusiness.industryTumor Necrosis Factor-alphaInterleukinsInterleukin-17GastroenterologyRectumColonoscopyMiddle AgedAcquired immune systemLymphocyte SubsetsIL-17Tumor necrosis factor alphaFemaleInterleukin 17medicine.symptombusinessCD8American journal of physiology. Gastrointestinal and liver physiology
researchProduct

Soluble tumor necrosis factor receptor type II in the early diagnosis of fever in neutropenia.

2002

Sepsis in chemotherapy-associated neutropenia is a major cause of mortality in the treatment of acute myeloid leukemia (AML). Early diagnosis of sepsis is crucial for patient survival. We analyzed the value of prospectively measuring serum concentrations of soluble tumor necrosis factor receptor type II (sTNF-RII) in patients with AML for early diagnosis of sepsis in neutropenia. Therefore, 54 adult patients with AML and neutropenia were followed around the onset of fever. A total of 59 febrile episodes were documented. We could not demonstrate a significant increase in sTNF-RII levels prior to fever. sTNF-RII concentrations were not predictive of the severity of a febrile episode. Based on…

AdultMalemedicine.medical_specialtyNeutropeniaTime FactorsFevermedicine.medical_treatmentPilot ProjectsNeutropeniaInfectionsGastroenterologySeverity of Illness IndexReceptors Tumor Necrosis FactorSepsisAntigens CDhemic and lymphatic diseasesInternal medicinemedicineHumansReceptors Tumor Necrosis Factor Type IIProspective StudiesAgedChemotherapyHematologyLeukopeniabusiness.industryOsmolar ConcentrationMyeloid leukemiaHematologyGeneral MedicineMiddle Agedmedicine.diseaseSolubilityLeukemia MyeloidImmunologyAcute DiseaseTumor necrosis factor alphaFemalemedicine.symptombusinessComplicationAnnals of hematology
researchProduct

Soluble CD14 monocyte antigen in suction blister fluid and serum of patients with psoriasis.

1993

The purpose of this study was to measure soluble CD14 (sCD14) molecules in the skin and in serum of patients with psoriasis. CD14 is a newly discovered cell surface marker on monocytes that is shed after cell activation. The following procedures were used: suction blisters were raised over the abdominal skin of 9 healthy control individuals and 8 patients with psoriasis. Serum of 17 healthy controls and 17 patients with psoriasis was collected. sCD14 was determined in suction blister fluid and serum by the ELISA technique. The clinical status of psoriasis was rated by the psoriasis area and severity index (PASI score). We found that sCD14 levels in suction blisters of healthy skin (1,050 +/…

AdultMalemedicine.medical_specialtyPathologyAdolescentLipopolysaccharide ReceptorsAntigens Differentiation MyelomonocyticDermatologySuctionGastroenterologySeverity of Illness IndexMonocytesBlisterAntigenPsoriasis Area and Severity IndexAntigens CDPsoriasisImmunopathologyInternal medicinemedicineHumansPsoriasisAgedintegumentary systembusiness.industryMonocyteBlistersMiddle Agedmedicine.diseaseSuction blisterBody Fluidsmedicine.anatomical_structureFemalemedicine.symptomCell activationbusinessDermatology (Basel, Switzerland)
researchProduct

Phenotypic analysis of peripheral lymphocyte subpopulations in hydatid patients.

1999

Peripheral T-lymphocytes were analyzed in three groups of people: (1) individuals with current liver hydatid disease (hydatid patients, n = 20), (2) persons who had undergone surgical cyst removal at least 2 years previously (recovered patients, n = 9), and (3) a control group of healthy volunteers (uninfected controls, n = 13). Group 1 was subdivided according to cyst status, relapse of disease, and the presence or absence of symptoms. Percentages of lymphocytes expressing CD3, CD4, CD8, CD56, CD25, CD45RA, CD45RO, and HLA-DR were determined. Symptomatic patients had proportionally fewer CD3+ CD8 + lymphocytes than the control group (P=0.038). Hydatid patients with active cysts had proport…

AdultMalemedicine.medical_specialtyPathologyEchinococcosis HepaticHelminthiasischemical and pharmacologic phenomenaBiologyGastroenterologyNatural killer cellImmunophenotypingImmune systemAntigens CDT-Lymphocyte SubsetsInternal medicineparasitic diseasesmedicineHumansCystIL-2 receptorEchinococcus granulosusAgedGeneral VeterinaryGeneral MedicineT lymphocyteMiddle Agedmedicine.diseasebiology.organism_classificationInfectious Diseasesmedicine.anatomical_structureInsect ScienceLeukocytes MononuclearParasitologyFemaleCD8Parasitology research
researchProduct